BioMed Research International / 2015 / Article / Tab 1

Clinical Study

Comparison of Propofol, Propofol-Remifentanil, and Propofol-Fentanyl Administrations with Each Other Used for the Sedation of Patients to Undergo ERCP

Table 1

Demographic and clinical features of the patients according to the groups.

VariablesGroup IGroup IIGroup III value

Age 51.6 ± 12.952.1 ± 16.450.3 ± 13.30.885
Gender M/F18/1218/1211/190.113
Weight73.8 ± 16.772.9 ± 11.869.1 ± 12.70.391
ASA 1/2/314/12/410/16/410/20/00.649
Diagnosis0.195
 Liver pathology16 (%53.3)19 (%63.3)23 (%76.7)
 Pancreas pathology4 (%13.3)6 (%20.0)4 (%13.3)
 Others10 (%33.3)5 (%16.7)3 (%10.0)
Additional disease14 (%46.7)19 (%63.3)18 (%60.0)0.387
Process time25 (15–50)25 (15–50)25 (15–50)0.595